NCT04818957View on ClinicalTrials.gov

Vitamin D Replacement Using Oral Thin Film (OTF) Cholecalciferol in Patients Undergoing Hematopoietic Stem Cell Transplantation

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 7, 2021

Primary Completion Date

April 6, 2022

Study Completion Date

April 20, 2022

Conditions
Vitamin D DeficiencyHematopoietic Stem Cell Transplantation (HSCT)
Interventions
DIETARY_SUPPLEMENT

Oral Thin Film (OTF) Cholecalciferol (Vitamin D3)

Study participants will receive vitamin D OTF weekly for a maximum of 12 weeks. The dose may be increased or decreased based on the dosing schema.

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER